I'd forgotten about this paper, but ended up looking into the complement system due to finding a ton of uncommon pathogenic mutations in the ME/CFS patients I have 23andMe data for. Basically we're putting together a new improved version of Analyze My Genes which now tags missense mutations and clinsig data, which includes flags such as "benign", "pathogenic", etc, and makes it easier to look for pathogenic missense mutations which are potentially compound heterozygous.
Anyhow, we're not getting a lot of pathogenic results on any particular SNP or gene, but overall we're getting quite a lot on the genes involved in the innate immune system, whereas our ethnically-matched controls have almost none. Also, the mutations turning up seem to be mostly or entirely down-regulations, resulting in diminished immune responses, primarily to various types of bacteria depending on the specific gene the mutation is on.
Most of these mutations aren't super rare. So far they're between 0.2% and about 6% prevalence in the general population. The genes I've had popping up so far are: C2, C3, C6, C7, ITGB2, FCN2, FCN3, MASP2, TLR4, CLEC7A, TIRAP, and CX3CR1. I'm going to look into them more to see if they're all resulting in some level of deficiency (instead of being up-regulations), and see if any more turn up.